本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Compass Therapeutics, Inc.

3.00
-0.1500-4.76%
盤後3.010.0100+0.33%19:04 EDT
成交量:66.25萬
成交額:202.14萬
市值:4.15億
市盈率:-7.49
高:3.22
開:3.20
低:2.97
收:3.15
資料載入中...
2021/03/05

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/01/14

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/17

重要事件披露

8-K - Current report
2020/11/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/19

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/09/23

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/18

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/15

重要事件披露

8-K - Current report
2020/08/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/31

重要事件披露

8-K/A [Amend] - Current report
2020/07/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/26

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/26

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/23

重要事件披露

8-K - Current report